Advances in the assessment of minimal residual disease in mantle cell lymphoma

The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Tags: Review Source Type: research